{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:56:53Z","timestamp":1784771813107,"version":"3.55.0"},"reference-count":26,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Vertical Project of Fujian Province","award":["2020CXB001"],"award-info":[{"award-number":["2020CXB001"]}]},{"name":"Science and Technology Innovation of Fujian province","award":["2021Y9024"],"award-info":[{"award-number":["2021Y9024"]}]},{"name":"Key Project of Natural Science Foundation of Fujian province","award":["2022J02048"],"award-info":[{"award-number":["2022J02048"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n               <jats:title>Background<\/jats:title>\n               <jats:p>Effective discrimination of lung adenocarcinoma (LUAD) <jats:italic>in situ<\/jats:italic> (AIS) from benign pulmonary nodules (BPN) is critical for the early diagnosis of AIS. Our pilot study in a small cohort of 90 serum samples has shown that serum interleukin 6 (IL-6) detection can distinguish AIS from BPN and health controls (HC). In this study, we intend to comprehensively define the diagnostic value of individual and combined detection of serum IL-6 related to the traditional tumor markers carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA21-1) for AIS.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Methods<\/jats:title>\n               <jats:p>The diagnostic performance of serum IL-6 along with CEA and CYFRA21-1 were evaluated in a large cohort of 300 serum samples by a chemiluminescence immunoassay and an electrochemiluminescence immunoassay. A training set comprised of 65 AIS, 65 BPN, and 65 HC samples was used to develop the predictive model for AIS. Data obtained from an independent validation set was applied to evaluate and validate the predictive model.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Results<\/jats:title>\n               <jats:p>In the training set, the levels of serum IL-6 and CEA in the AIS group were significantly higher than those in the BPN\/HC group (<jats:italic>P<\/jats:italic> &lt; 0.05). There was no significant difference in serum CYFRA21-1 levels between the AIS group and the BPN\/HC group (<jats:italic>P<\/jats:italic>&gt; 0.05). Serum IL-6 and CEA levels for AIS patients showed an area under the curve (AUC) of 0.622 with 23.1% sensitivity at 90.7% specificity, and an AUC of 0.672 with 24.6% sensitivity at 97.6% specificity, respectively. The combination of serum IL-6 and CEA presented an AUC of 0.739, with 60.0% sensitivity at 95.4% specificity. The combination of serum IL-6 and CEA showed an AUC of 0.767 for AIS patients, with 57.1% sensitivity at 91.4% specificity in the validation set.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Conclusions<\/jats:title>\n               <jats:p>IL-6 shows potential as a prospective serum biomarker for the diagnosis of AIS, and the combination of serum IL-6 with CEA may contribute to increased accuracy in AIS diagnosis. However, it is worth noting that further research is still necessary to validate and optimize the diagnostic efficacy of these biomarkers and to address potential sensitivity limitations.<\/jats:p>\n            <\/jats:sec>","DOI":"10.7717\/peerj.17141","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T09:16:04Z","timestamp":1711098964000},"page":"e17141","source":"Crossref","is-referenced-by-count":5,"title":["Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma <i>in situ<\/i>"],"prefix":"10.7717","volume":"12","author":[{"given":"Jing","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China"},{"name":"Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzhen","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China"},{"name":"Department of Clinical Laboratory, Fujian Provincial Hospital, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Fujian Provincial Hospital, Fuzhou, China"},{"name":"Integrated Chinese and Western Medicine College, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Fujian Provincial Hospital, Fuzhou, China"},{"name":"Integrated Chinese and Western Medicine College, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zheng","sequence":"additional","affiliation":[{"name":"Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China"},{"name":"Department of Clinical Laboratory, Fujian Provincial Hospital, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[{"name":"Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China"},{"name":"Department of Clinical Laboratory, Fujian Provincial Hospital, Fuzhou, China"},{"name":"Center for Experimental Research in Clinical Medicine, Fujian Provincial Hospital, Fuzhou, Fujian, China"},{"name":"Fujian Provincial Key Laboratory of Critical Care Medicine, Fujian Provincial Key Laboratory of Cardiovascular Disease, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"issue":"6","key":"10.7717\/peerj.17141\/ref-1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1172\/JCI114392","article-title":"Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias","volume":"84","author":"Bataille","year":"1989","journal-title":"Journal of Clinical Investigation"},{"issue":"24","key":"10.7717\/peerj.17141\/ref-2","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.3390\/cancers15245757","article-title":"Interleukin-6 induces stem cell propagation through Liaison with the sortilin-progranulin axis in breast cancer","volume":"15","author":"Berger","year":"2023","journal-title":"Cancers"},{"issue":"7","key":"10.7717\/peerj.17141\/ref-3","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1007\/s00432-022-04217-5","article-title":"Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030","volume":"149","author":"Fang","year":"2023","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"12","key":"10.7717\/peerj.17141\/ref-4","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.3390\/life13122261","article-title":"Correlation of the pro-inflammatory cytokines IL-1 \u03b2, IL-6, and TNF- \u03b1, inflammatory markers, and tumor markers with the diagnosis and prognosis of colorectal cancer","volume":"13","author":"Florescu","year":"2023","journal-title":"Life"},{"issue":"4","key":"10.7717\/peerj.17141\/ref-5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.rmed.2003.10.010","article-title":"Elevation of cytokeratin 19 fragment (CYFRA 21-1) in serum of patients with radiation pneumonitis: possible marker of epithelial cell damage","volume":"98","author":"Fujita","year":"2004","journal-title":"Respiratory Medicine"},{"key":"10.7717\/peerj.17141\/ref-6","doi-asserted-by":"publisher","first-page":"155358","DOI":"10.1016\/j.cyto.2020.155358","article-title":"Cytokine profiles in patients with newly diagnosed multiple myeloma: survival is associated with IL-6 and IL-17A levels","volume":"138","author":"Gu","year":"2021","journal-title":"Cytokine"},{"issue":"2","key":"10.7717\/peerj.17141\/ref-7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry","year":"2012","journal-title":"Molecular Oncology"},{"issue":"2","key":"10.7717\/peerj.17141\/ref-8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1148\/radiol.12102489","article-title":"Lung cancer diagnosed at annual CT screening: volume doubling times","volume":"263","author":"Henschke","year":"2012","journal-title":"Radiology"},{"key":"10.7717\/peerj.17141\/ref-9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"International Immunology"},{"issue":"4","key":"10.7717\/peerj.17141\/ref-10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jtho.2019.11.030","article-title":"Validation of the eighth edition TNM lung cancer staging system","volume":"15","author":"Hwang","year":"2020","journal-title":"Journal of Thoracic Oncology"},{"key":"10.7717\/peerj.17141\/ref-11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/LCTT.S23424","article-title":"Update on biomarkers for the detection of lung cancer","volume":"3","author":"Jantus-Lewintre","year":"2012","journal-title":"Lung Cancer"},{"issue":"9","key":"10.7717\/peerj.17141\/ref-12","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1002\/1097-0142(20011101)92:9<2399::AID-CNCR1588>3.0.CO;2-W","article-title":"Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma","volume":"92","author":"Kasuga","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.7717\/peerj.17141\/ref-13","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.21037\/tcr-21-527","article-title":"The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancer","volume":"10","author":"Li","year":"2021","journal-title":"Translational Cancer Research"},{"issue":"3","key":"10.7717\/peerj.17141\/ref-14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.athoracsur.2021.06.091","article-title":"Benefit of three-dimensional image simulation in surgical resection of early-stage lung cancer","volume":"114","author":"Lin","year":"2022","journal-title":"The Annals of Thoracic Surgery"},{"issue":"3-4","key":"10.7717\/peerj.17141\/ref-15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3233\/CBM-2012-0246","article-title":"The prognostic values of CA125, CA19.9, NSE, and SCC for stage I NSCLC are limited","volume":"10","author":"Ma","year":"2011","journal-title":"Cancer Biomarkers"},{"issue":"2","key":"10.7717\/peerj.17141\/ref-16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0169-5002(95)00485-8","article-title":"CEA, CYFRA21-1 and SCC in non-small cell lung cancer","volume":"13","author":"Moro","year":"1995","journal-title":"Lung Cancer"},{"key":"10.7717\/peerj.17141\/ref-17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.lungcan.2016.07.024","article-title":"Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung","volume":"100","author":"Naito","year":"2016","journal-title":"Lung Cancer"},{"issue":"2","key":"10.7717\/peerj.17141\/ref-18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1148\/rg.272065061","article-title":"Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow up","volume":"27","author":"Park","year":"2007","journal-title":"Radio Graphics"},{"issue":"9","key":"10.7717\/peerj.17141\/ref-19","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1200\/JCO.2010.31.8907","article-title":"Targeting the interleukin-6\/JAk\/STAT3 pathway in human malignancies","volume":"30","author":"Sansone","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.7717\/peerj.17141\/ref-20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.chest.2017.03.019","article-title":"Low-dose computed tomography for lung cancer screening: clinical and coding considerations","volume":"152","author":"Shieh","year":"2017","journal-title":"Chest"},{"issue":"9","key":"10.7717\/peerj.17141\/ref-21","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.jtho.2016.05.025","article-title":"IL-6 secreted from cancer-associated fibroblasts mediates chemoresistance in NSCLC by increasing epithelial-mesenchymal transition signaling","volume":"11","author":"Shintani","year":"2016","journal-title":"Journal of Thoracic Oncology"},{"issue":"10","key":"10.7717\/peerj.17141\/ref-22","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/cancers15245757","article-title":"Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"issue":"8","key":"10.7717\/peerj.17141\/ref-23","doi-asserted-by":"publisher","first-page":"e09953","DOI":"10.1016\/j.heliyon.2022.e09953","article-title":"Prognosis value of IL-6, IL-8, and IL-1 \u03b2 in serum of patients with lung cancer: a fresh look at interleukins as a biomarker","volume":"13","author":"Yan","year":"2022","journal-title":"Heliyon"},{"issue":"5","key":"10.7717\/peerj.17141\/ref-24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/bjc.1995.212","article-title":"Serum levels of inter-leukin-6 in patients with lung cancer","volume":"71","author":"Yanagawa","year":"1995","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10.7717\/peerj.17141\/ref-25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Translational Lung Cancer Research"},{"issue":"19","key":"10.7717\/peerj.17141\/ref-26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/cddis.2014.263","article-title":"The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression","volume":"6","author":"Zhu","year":"2014","journal-title":"Cell Death & Disease"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/17141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/17141.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/17141.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/17141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T09:16:20Z","timestamp":1711098980000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/17141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":26,"alternative-id":["10.7717\/peerj.17141"],"URL":"https:\/\/doi.org\/10.7717\/peerj.17141","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"article-number":"e17141"}}